These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 16147848)

  • 1. Maternal plasma transforming growth factor-beta1 concentrations in preeclamptic and normotensive pregnant Zimbabwean women.
    Enquobahrie DA; Williams MA; Qiu C; Woelk GB; Mahomed K
    J Matern Fetal Neonatal Med; 2005 May; 17(5):343-8. PubMed ID: 16147848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming growth factor-beta1 (TGF-beta1) in plasma is associated with preeclampsia risk in Peruvian women with systemic inflammation.
    Muy-Rivera M; Sanchez SE; Vadachkoria S; Qiu C; Bazul V; Williams MA
    Am J Hypertens; 2004 Apr; 17(4):334-8. PubMed ID: 15062887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated soluble vascular cell adhesion molecule-1, elevated Homocyst(e)inemia, and hypertriglyceridemia in relation to preeclampsia risk.
    Vadachkoria S; Woelk GB; Mahomed K; Qiu C; Muy-Rivera M; Malinow MR; Williams MA
    Am J Hypertens; 2006 Mar; 19(3):235-42. PubMed ID: 16500507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma tumor necrosis factor-alpha soluble receptor p55 (sTNFp55) concentrations in eclamptic, preeclamptic and normotensive pregnant Zimbabwean women.
    Williams MA; Mahomed K; Farrand A; Woelk GB; Mudzamiri S; Madzime S; King IB; McDonald GB
    J Reprod Immunol; 1998 Nov; 40(2):159-73. PubMed ID: 9881743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered plasma concentrations of leptin, transforming growth factor-beta(1) and plasminogen activator inhibitor type 2 at 18 weeks of gestation in women destined to develop pre-eclampsia. Circulating markers of disturbed placentation?
    Clausen T; Djurovic S; Reseland JE; Berg K; Drevon CA; Henriksen T
    Placenta; 2002 May; 23(5):380-5. PubMed ID: 12061853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal plasma VEGF, sVEGF-R1, and PlGF concentrations in preeclamptic and normotensive pregnant Zimbabwean women.
    Muy-Rivera M; Vadachkoria S; Woelk GB; Qiu C; Mahomed K; Williams MA
    Physiol Res; 2005; 54(6):611-22. PubMed ID: 15717861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukocyte selenium, zinc, and copper concentrations in preeclamptic and normotensive pregnant women.
    Mahomed K; Williams MA; Woelk GB; Mudzamiri S; Madzime S; King IB; Bankson DD
    Biol Trace Elem Res; 2000; 75(1-3):107-18. PubMed ID: 11051601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of maternal plasma leptin and risk of pre-eclampsia: a prospective study.
    Ning Y; Williams MA; Muy-Rivera M; Leisenring WM; Luthy DA
    J Matern Fetal Neonatal Med; 2004 Mar; 15(3):186-92. PubMed ID: 15280145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet aggregation and TGF-beta(1) plasma levels in pregnant women with preeclampsia.
    Peraçoli MT; Menegon FT; Borges VT; de Araújo Costa RA; Thomazini-Santos IA; Peraçoli JC
    J Reprod Immunol; 2008 Oct; 79(1):79-84. PubMed ID: 18805591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case-control study of oxidized low density lipoproteins and preeclampsia risk.
    Sanchez SE; Williams MA; Muy-Rivera M; Qiu C; Vadachkoria S; Bazul V
    Gynecol Endocrinol; 2005 Oct; 21(4):193-9. PubMed ID: 16316839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for preeclampsia-eclampsia among Zimbabwean women: recurrence risk and familial tendency towards hypertension.
    Mahomed K; Williams MA; Woelk GB; Jenkins-Woelk L; Mudzamiri S; Madzime S; Sorensen TK
    J Obstet Gynaecol; 1998 May; 18(3):218-22. PubMed ID: 15512062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal plasma lipid concentrations in early pregnancy and risk of preeclampsia.
    Enquobahrie DA; Williams MA; Butler CL; Frederick IO; Miller RS; Luthy DA
    Am J Hypertens; 2004 Jul; 17(7):574-81. PubMed ID: 15233976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor beta(1) levels in platelet depleted plasma in African women with pre-eclampsia.
    Naicker T; Khedun SM; Moodley J
    J Obstet Gynaecol; 2002 May; 22(3):279-82. PubMed ID: 12521499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal serum transforming growth factor beta-2 in preeclampsia and eclampsia, a potential biomarker for the assessment of disease severity and fetal outcome.
    Shaarawy M; El Meleigy M; Rasheed K
    J Soc Gynecol Investig; 2001; 8(1):27-31. PubMed ID: 11223354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor beta-1 influence on fetal allografts during pregnancy.
    Ayatollahi M; Geramizadeh B; Samsami A
    Transplant Proc; 2005 Dec; 37(10):4603-4. PubMed ID: 16387180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal plasma concentrations of insulinlike growth factor-1 and insulinlike growth factor-binding protein-1 in early pregnancy and subsequent risk of preeclampsia.
    Ning Y; Williams MA; Vadachkoria S; Muy-Rivera M; Frederick IO; Luthy DA
    Clin Biochem; 2004 Nov; 37(11):968-73. PubMed ID: 15498523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cystatin C and preeclampsia: a case control study.
    Franceschini N; Qiu C; Barrow DA; Williams MA
    Ren Fail; 2008; 30(1):89-95. PubMed ID: 18197549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum heat shock protein 70 levels in relation to circulating cytokines, chemokines, adhesion molecules and angiogenic factors in women with preeclampsia.
    Molvarec A; Szarka A; Walentin S; Beko G; Karádi I; Prohászka Z; Rigó J
    Clin Chim Acta; 2011 Oct; 412(21-22):1957-62. PubMed ID: 21756887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble tumor necrosis factor receptors and interleukin-6 levels in patients with severe preeclampsia.
    Kupferminc MJ; Peaceman AM; Aderka D; Wallach D; Socol ML
    Obstet Gynecol; 1996 Sep; 88(3):420-7. PubMed ID: 8752252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An elevated maternal plasma, but not amniotic fluid, soluble fms-like tyrosine kinase-1 (sFlt-1) at the time of mid-trimester genetic amniocentesis is a risk factor for preeclampsia.
    Park CW; Park JS; Shim SS; Jun JK; Yoon BH; Romero R
    Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):984-9. PubMed ID: 16157098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.